Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

• Author(s): Nahas, William Carlos
• Date: 2019
• Origin: Oasisbr
• Subject(s): ANDRÓGENOS
• Document Type: Journal article
• Language: English